| Lou HY |
------>authors3_c= ------>paper_class1=1 ------>Impact_Factor=2.177 ------>paper_class3=2 ------>paper_class2=1 ------>vol=0 ------>confirm_bywho=ncchang ------>insert_bywho=chunchao ------>Jurnal_Rank=47.3 ------>authors4_c= ------>comm_author= ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2=0 ------>medlineContent= ------>unit=E0109 ------>insert_date=20081126 ------>iam=1 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c= ------>score=-10000 ------>journal_name=Eur J Clin Pharmacol 2008 (article in press) ------>paper_name=Optimal dose regiments of esomeprazole for gastric acid suppression with minimal influence of CYP2C19 polymorphism ------>confirm_date=20081201 ------>tch_id=085061 ------>pmid=no found ------>page1=0 ------>fullAbstract=no found ------>tmu_sno=None ------>sno=19893 ------>authors2=Chang CC ------>authors3=Sheu MT ------>authors4=Chen YC ------>authors5=Ho HO ------>authors6= ------>authors6_c= ------>authors=Lou HY ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=0 ------>updateTitle=no found ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=0 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2008 ------>submit_flag=None ------>publish_month=1 |